We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.73B
AUM Growth
-$32.7M
Cap. Flow
-$304M
Cap. Flow %
-5.3%
Top 10 Hldgs %
52.96%
Holding
258
New
61
Increased
37
Reduced
51
Closed
64

Top Buys

Rank Stock Value
1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$103M
2
AMZN icon
Amazon
AMZN
+$91.5M
3
BIIB icon
Biogen
BIIB
+$49.7M
4
PARA
Paramount Global Class B
PARA
+$49.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$48.3M

Top Sells

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$101M
2
ROST icon
Ross Stores
ROST
+$100M
3
FIVE icon
Five Below
FIVE
+$76.2M
4
LULU icon
lululemon athletica
LULU
+$76.1M
5
INCY icon
Incyte
INCY
+$73M

Sector Composition

Rank Sector Weight
1 Healthcare 45.98%
2 Consumer Staples 5.76%
3 Technology 4.46%
4 Consumer Discretionary 4.37%
5 Communication Services 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CENTA icon
26
Central Garden & Pet Co Class A
CENTA
$2.39B
$54M 0.94%
1,886,250
-51,250
-3% -$1.54M
MSFT icon
27
Microsoft
MSFT
$3.62T
$53.7M 0.94%
224,000
+63,000
+39% +$15.1M
ISRG icon
28
Intuitive Surgical
ISRG
$135B
$53.1M 0.93%
200,000
-28,000
-12% -$6.83M
MDT icon
29
Medtronic
MDT
$111B
$52.2M 0.91%
672,000
-52,000
-7% -$4.21M
CVS icon
30
CVS Health
CVS
$134B
$44.4M 0.77%
+476,000
New +$45.9M
VRTX icon
31
Vertex Pharmaceuticals
VRTX
$119B
$42.7M 0.75%
148,000
-2,000
-1% -$610K
NVO
32
Novo Nordisk
NVO
$208B
$42.2M 0.74%
+624,000
New +$36.6M
CRSP icon
33
CRISPR Therapeutics
CRSP
$4.88B
$42.1M 0.73%
1,036,000
+112,000
+12% +$5.94M
MGNX icon
34
MacroGenics
MGNX
$243M
$40.9M 0.71%
6,092,000
-36,000
-0.6% -$197K
ISEE
35
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$38.4M 0.67%
1,792,000
+428,000
+31% +$9.13M
BHVN icon
36
Biohaven
BHVN
$2.01B
$37.8M 0.66%
2,724,000
+1,259,064
+86% +$17.8M
EVBG
37
DELISTED
Everbridge, Inc. Common Stock
EVBG
$31.7M 0.55%
1,072,000
+316,000
+42% +$9.69M
BABA icon
38
Alibaba
BABA
$305B
$31.4M 0.55%
356,000
+32,000
+10% +$2.52M
BUD icon
39
AB InBev
BUD
$166B
$29.9M 0.52%
498,000
-650,000
-57% -$34.9M
POST icon
40
Post Holdings
POST
$4.09B
$28.6M 0.5%
317,000
-7,000
-2% -$624K
KHC icon
41
Kraft Heinz
KHC
$31.3B
$28.1M 0.49%
690,000
-960,000
-58% -$36.5M
ENR icon
42
Energizer
ENR
$1.45B
$27.6M 0.48%
824,000
-728,000
-47% -$22.4M
XRAY icon
43
Dentsply Sirona
XRAY
$2.83B
$26.6M 0.46%
+836,000
New +$25.2M
ADBE icon
44
Adobe
ADBE
$99.9B
$26.2M 0.46%
78,000
-106,000
-58% -$33.9M
RIGL icon
45
Rigel Pharmaceuticals
RIGL
$693M
$25.4M 0.44%
1,695,600
+1,350,313
+391% +$12.4M
CLX icon
46
Clorox
CLX
$11.9B
$24.3M 0.42%
+173,000
New +$24.6M
DOCU
47
DocuSign
DOCU
$10.5B
$23.1M 0.4%
+416,000
New +$20.3M
TOST icon
48
Toast
TOST
$19B
$22.6M 0.4%
1,256,000
+92,000
+8% +$1.73M
AUPH icon
49
Aurinia Pharmaceuticals
AUPH
$1.87B
$21.6M 0.38%
5,000,000
+4,276,000
+591% +$24.8M
UNH icon
50
UnitedHealth
UNH
$377B
$21.2M 0.37%
40,000
+16,000
+67% +$8.48M
1
2
3 4 5

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return

Armistice Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Armistice Capital held 258 positions worth $5.73B, down 0.57% from $5.76B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Armistice Capital withdrew a net $304M in Q4 2022, closing 64 positions and reducing 51 holdings. Its most notable exit was Five Below, an estimated $76.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 43% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Armistice Capital opened a new position in CVS Health worth $44.4M.

  • Armistice Capital's largest Q4 2022 buy was CVS Health: 476,000 shares worth $44.4M.
  • Armistice Capital added most to Mirati Therapeutics, Inc. Common Stock in Q4 2022, an estimated $103M increase.
  • Armistice Capital's biggest Q4 2022 reduction was Madrigal Pharmaceuticals, cutting an estimated $101M.
  • Armistice Capital fully exited Five Below in Q4 2022, selling an estimated $76.2M.
  • Armistice Capital's ten largest holdings make up 53% of its $5.73B portfolio in Q4 2022.
  • Armistice Capital opened 61 new positions and closed 64 in Q4 2022.
  • Armistice Capital's portfolio value fell 0.57% quarter-over-quarter to $5.73B.

Based on Armistice Capital's 13F filing for Q4 2022, filed 14 Feb 2023.